Onychomycosis not associated with poor COVID-19 clinical outcomes in a retrospective cohort study at an academic institution, New York, New York - 13/12/23
Doi : 10.1016/j.jaad.2023.08.081
Kaya L. Curtis, BA a, Rhiannon C. Miller, MD b, Amar D. Desai, MPH c, Shari R. Lipner, MD, PhD b, ⁎ 
a Weill Cornell Medical College, New York, New York
b Department of Dermatology, Weill Cornell Medicine, New York, New York
c Rutgers New Jersey Medical School, Newark, New Jersey
∗Correspondence to: Shari R. Lipner, MD, PhD, Weill Cornell Department of Dermatology, 1305 York Avenue, New York, NY 10021Weill Cornell Department of Dermatology1305 York AvenueNew YorkNY10021
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : coronavirus, COVID-19, dermatophyte, fungus, nail disorders, onychomycosis
| Funding sources: None. |
|
| IRB approval status: Approved by the Weill Cornell Medicine Institutional Review Board (#21-08023827). |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 1
P. 153-156 - janvier 2024 Retour au numéro
Article précédent
- Cost of skin cancer-related dermatological care is higher in transplant recipients compared with nonimmunosuppressed patients
- Katie A. O’Connell, Morgan K. Groover, Subin Lim, Kylee J.B. Kus, Neha Gupta, Fadi Murad, Emily S. Ruiz
- Factors affecting follow-up adherence following Mohs micrographic surgery in patients with nonmelanoma skin cancer: A retrospective chart review
- Sumrah Jilani, Nina M. D'Amiano, Katherine G. Thompson, Jeremy Ellis, Anjali D'Amiano, Elena Wei, Kristin P. Bibee, Jeffrey F. Scott
Bienvenue sur EM-consulte, la référence des professionnels de santé.